| 1 |
34287884 | Retraction. | 2022 Mar |
1 |
| 2 |
34969766 | Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen. | 2022 Jan |
3 |
| 3 |
35054486 | Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. | 2022 Jan 10 |
1 |
| 4 |
35066343 | 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages. | 2022 Mar |
1 |
| 5 |
35125086 | Nimbolide, a Neem Limonoid, Inhibits Angiogenesis in Breast Cancer by Abrogating Aldose Reductase Mediated IGF-1/PI3K/Akt Signalling. | 2022 |
1 |
| 6 |
35169858 | Inhibition of the VEGF signaling pathway attenuates tumor‑associated macrophage activity in liver cancer. | 2022 Apr |
2 |
| 7 |
35559394 | LncRNA TTN-AS1 confers tamoxifen resistance in breast cancer via sponging miR-107 to modulate PI3K/AKT signaling pathway. | 2022 |
2 |
| 8 |
33755174 | Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells. | 2021 Sep 11 |
1 |
| 9 |
33800852 | Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer. | 2021 Mar 6 |
1 |
| 10 |
33861751 | CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells. | 2021 |
3 |
| 11 |
34149926 | HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer. | 2021 |
1 |
| 12 |
34182538 | GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells. | 2021 Jun 28 |
1 |
| 13 |
34326682 | Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway. | 2021 |
2 |
| 14 |
34370280 | PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor prognosis in breast cancer patients. | 2021 Nov |
5 |
| 15 |
34424807 | Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein kinase B axis. | 2021 Dec |
1 |
| 16 |
34619972 | Tumor-associated macrophages increase COX-2 expression promoting endocrine resistance in breast cancer via the PI3K/Akt/mTOR pathway. | 2021 Sep |
1 |
| 17 |
34771077 | Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance. | 2021 Nov 3 |
1 |
| 18 |
31604073 | Knockdown of PTEN decreases expression of estrogen receptor β and tamoxifen sensitivity of human breast cancer cells. | 2020 Jan |
1 |
| 19 |
31710162 | Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer. | 2020 Jan |
1 |
| 20 |
31894313 | Metformin alleviates endometrial hyperplasia through the UCA1/miR‑144/TGF‑β1/AKT signaling pathway. | 2020 Feb |
1 |
| 21 |
32417506 | CXCL10 mediates breast cancer tamoxifen resistance and promotes estrogen-dependent and independent proliferation. | 2020 Jul 15 |
1 |
| 22 |
32668964 | MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway. | 2020 |
1 |
| 23 |
32691010 | CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation. | 2020 Sep 25 |
1 |
| 24 |
32921987 | Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer. | 2020 |
2 |
| 25 |
33177647 | Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells. | 2020 Nov 11 |
1 |
| 26 |
33318536 | Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells. | 2020 Dec 14 |
5 |
| 27 |
30145819 | Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway. | 2019 Feb |
5 |
| 28 |
30304547 | Tamoxifen ameliorates obstructive nephropathy through Src and the PI3K/Akt/mTOR pathway. | 2019 Jan |
5 |
| 29 |
30680659 | Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES. | 2019 May |
1 |
| 30 |
30795784 | Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer. | 2019 Feb 22 |
1 |
| 31 |
30890553 | Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy. | 2019 Jul 1 |
1 |
| 32 |
31088266 | Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway. | 2019 Jan 1 |
1 |
| 33 |
31202170 | MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway. | 2019 Sep |
1 |
| 34 |
31657150 | Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. | 2019 Dec |
1 |
| 35 |
29248549 | A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer. | 2018 Mar |
1 |
| 36 |
29620287 | Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36. | 2018 Jun |
1 |
| 37 |
29787277 | Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer. | 2018 Jul 2 |
3 |
| 38 |
29945962 | Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer. | 2018 Sep 1 |
1 |
| 39 |
30076704 | AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells. | 2018 Jan |
2 |
| 40 |
30154367 | SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment. | 2018 Aug 28 |
2 |
| 41 |
27838413 | MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial-mesenchymal transition, decreased ERα expression and AKT activation. | 2017 Feb 1 |
2 |
| 42 |
28852212 | Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen. | 2017 Aug 29 |
2 |
| 43 |
28855026 | Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells. | 2017 Dec |
3 |
| 44 |
29179465 | Shikonin reduces tamoxifen resistance through long non-coding RNA uc.57. | 2017 Oct 24 |
2 |
| 45 |
26892736 | The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling. | 2016 Apr |
1 |
| 46 |
27027343 | Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells. | 2016 May 3 |
1 |
| 47 |
27262235 | Tamoxifen-induced cytotoxicity in breast cancer cells is mediated by glucose-regulated protein 78 (GRP78) via AKT (Thr308) regulation. | 2016 Aug |
8 |
| 48 |
27633191 | Determination of the optimal time for tamoxifen treatment in combination with radiotherapy. | 2016 Nov |
2 |
| 49 |
25490383 | Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells. | 2015 Jan 2 |
1 |
| 50 |
25727020 | Omega-3 free fatty acids inhibit tamoxifen-induced cell apoptosis. | 2015 Apr 3 |
3 |